The results of a study conducted in chemosensitive patient-derived xenograft (PDX) models of SCLC revealed that inactivation of N-MYC restores cancer cell chemosensitivity through downregulation of ubiquitin-specific protease 7 (USP7) expression [174]. Here, USP7 is linked to cancer.